Crohn’s & Colitis Professional - Crohn's Colitis Professional

Crohn’s & Colitis Professional Hero

IBD Clinical Hub

Discover up-to-date educational resources to enhance your knowledge of Crohn's disease and ulcerative colitis

Featured

APP Biosimilar Education Video Series Module 1
APP Biosimilar Education Video Series Module 1
Medical Therapy
APP Biosimilar Education Video Series Module 1
Donna Bacchus, PhD, MSN, RN; Juanita Belton, MPH, PA-C
- Donna Bacchus, PhD, MSN, RN
- Juanita Belton, MPH, PA-C
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
Surgical Therapy
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
Stefan Holubar, MD, MS
- Stefan Holubar, MD, MS
Achieving Successful Transition of IBD Pediatric Patients to Adult Care
Achieving Successful Transition of IBD Pediatric Patients to Adult Care
Health Maintenance
Achieving Successful Transition of IBD Pediatric Patients to Adult Care

Popular

IBDPro: 2026 IBD Pharmacist Virtual Symposium
IBDPro: 2026 IBD Pharmacist Virtual Symposium
Practice Resources & Guidelines
IBDPro: 2026 IBD Pharmacist Virtual Symposium
IBDPro: Obesity & IBD Educational Webinar for Healthcare Professionals
IBDPro: Obesity & IBD Educational Webinar for Healthcare Professionals
Practice Resources & Guidelines
IBDPro: Obesity & IBD Educational Webinar for Healthcare Professionals
Defining Success in IBD: Treat-to-Target
Defining Success in IBD: Treat-to-Target
MinuteCE®
Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD; Ugo Iroku, MD, MHS
2.00 program credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 program credits
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
MinuteCE®
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Where Conventional IBD Therapies Fall Short
Where Conventional IBD Therapies Fall Short
MinuteCE®
Where Conventional IBD Therapies Fall Short
Ugo Iroku, MD, MHS; Michael Dolinger, MD, MBA
2.00 program credits
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
2.00 program credits
The Future of Biologic Treatment in IBD: What’s on the Horizon
The Future of Biologic Treatment in IBD: What’s on the Horizon
MinuteCE®
The Future of Biologic Treatment in IBD: What’s on the Horizon
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Navigating IBD Guidelines: What Clinicians Need to Know Now
Navigating IBD Guidelines: What Clinicians Need to Know Now
MinuteCE®
Navigating IBD Guidelines: What Clinicians Need to Know Now
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits

Clinical Topics

IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
Practice Resources & Guidelines
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
The Future of IBD Therapy: Expert Perspectives on Biosimilars
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Medical Therapy
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI; Ross M. Maltz, MD
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Ross M. Maltz, MD
- Melissa Kirkpatrick, PharmD, BCACP
Scripps Conference: New Advances in Inflammatory Bowel Disease
PROactive isn’t PRO-science: When scientists go rogue!
Scripps Conference: New Advances in Inflammatory Bowel Disease
PROactive isn’t PRO-science: When scientists go rogue!
Medical Therapy
Scripps Conference: New Advances in Inflammatory Bowel Disease
PROactive isn’t PRO-science: When scientists go rogue!
Siddharth Singh, MD
- Siddharth Singh, MD
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Medical Therapy
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc; Siddharth Singh, MD
- Ryan W. Stidham, MD, MSc
- Siddharth Singh, MD